Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 8821-8830 of 13159

Page
per page
  1. Z-Phe-Leu-OH
    C8175 Z-Phe-Leu-OH
    Summary: Substrate for carboxypeptidase y (CPY).
  2. HRO761
    A9929 HRO761
    Summary: A DNA helicase inhibitor
      ≥25.3 mg/mL
  3. AZ31
    BA3716 AZ31
    Summary: AZ31 is a potent, highly selective, orally active inhibitor.
  4. MNI 137
    B5571 MNI 137
    Summary: negative allosteric modulator of group II mGlu receptors
      <17.06 mg/mL
  5. ISX 9
    B5596 ISX 9
    Summary: neurogenic agent
      ≥23.4 mg/mL
  6. BAY 60-6583
    B5612 BAY 60-6583
    Target: Adenosine A2B Receptors
    Summary: Potent A2B receptor agonist
      ≥36.1 mg/mL
  7. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: orally bioavailable dual MER/FLT3 inhibitor
      ≥23.85 mg/mL
  8. LDN 209929 dihydrochloride
    B7785 LDN 209929 dihydrochloride
    Target: haspin kinase
    Summary: haspin kinase inhibitor
      <40.58 mg/mL
  9. HSP990 (NVP-HSP990)
    B4797 HSP990 (NVP-HSP990)
    Target: HSP90
    Summary: Hsp90 inhibitor, potent and selective
      insoluble in H2O; insoluble in EtOH; ≥12.3 mg/mL
  10. PF-06463922
    B4882 PF-06463922
    Target: ALK|ROS1
    Summary: ALK/ROS1 inhibitor,potent and selective
      insoluble in H2O; ≥20.3 mg/mL

Items 8821-8830 of 13159

Page
per page